期刊文献+

叶下珠复方Ⅱ号对二甲基亚硝胺诱导大鼠肝纤维化形成的抑制作用 被引量:12

Prophylactic Effects of Compound Phyllanthus Urinaria Ⅱ on Liver Fibrosis in Rats Induced by Dimethylnitrosamine
下载PDF
导出
摘要 目的:观察叶下珠复方Ⅱ号抗大鼠实验性肝纤维化的作用效果并探讨其作用机制。方法:采用二甲基亚硝胺诱导的大鼠肝纤维化模型,用高、中、低三种剂量(100g/kg,50g/kg,25g/kg)的叶下珠复方Ⅱ号水提液进行干预治疗,并与秋水仙碱进行对照,检测大鼠肝功能、肝组织羟脯胺酸(Hyp)、丙二醛(MDA)、血清透明质酸(HA)含量及肝脏病理组织学改变。结果:叶下珠复方Ⅱ号高、中、低剂量组谷草转氨酶(AST)、γ-谷氨酰转移酶(GGT)、碱性磷酸酶(ALP)、总胆红素(TBIL)和直接胆红素(DBIL)均显著低于模型组,差异均有显著性意义(P<0.05)。叶下珠复方Ⅱ号中剂量组大鼠肝组织Hyp、MDA和血清HA含量均明显低于模型组,差异均有显著性意义(P<0.05);与秋水仙碱组比较,差异均有显著性意义(P<0.01)。叶下珠复方Ⅱ号高、中、低剂量组肝组织纤维化病变明显减轻,与模型组比较,差异均有显著性意义(P<0.01)。结论:叶下珠复方Ⅱ号对二甲基亚硝胺诱导的肝纤维化形成具有明显的抑制作用,其机制与抗脂质过氧化损伤、保护肝细胞和抑制胶原纤维合成有关。 Objective:To investigate the prophylactic effect of Compound Phyllanthus Urinaria Ⅱ( CPU Ⅱ) on experimental liver fibrosis in rats induced by dimethylnitrosamine(DMN) and to reveal its mechanism. Methods: By establishing the models of DMN-induced liver fibrosis in rats, we observed the prophylactic effect of CPU II with high, middle and low dosage group( 100g/ kg,50g/kg and 25g/kg respectively. ), and colchicinum as the positive control. Serum Index of liver function, contents of hydroxyproline(Hyp) ,malodialdehyde (MDA) in liver tissue and serum hyaluronic acid(HA) were determined,the liver pathological change was observed. Resu/ts :It showed that serum levels of AST,ALP,GGT,TBIL and DBIL in high, middle and low dosage groups of CPU Ⅱ were all obviously lower to those of model group(P 〈0. 05). Contents of Hyp,MDA in liver tissue and HA in serum were remarkable lower to those of model group ( P 〈 0. 05 ) and colchicinum group ( P 〈 0. 01 ). Hepatic fibrosis histopathological changes were remarkable alleviated in three dosage groups of CPU Ⅱ comparing with those of model group ( P 〈 0. 05 ). Conclusion: It showed that CPU Ⅱ has a remarkable prophylactic effect on DMN-induced liver fibrosis in rats, probably by protecting hepatocyte and suppressing fibrosis accumulation through anti-lipopeioxidation.
出处 《辽宁中医杂志》 CAS 北大核心 2009年第8期1413-1415,共3页 Liaoning Journal of Traditional Chinese Medicine
基金 广州市荔湾区科技计划资助项目(2008210933) 广州中医药大学科研创新基金资助项目(2005C071)
关键词 叶下珠复方Ⅱ号 肝纤雏化 二甲基亚硝胺 大鼠 compound phyllanthusurinaria Ⅱ liver fibrosis dimethylnitrosamine rat
  • 相关文献

参考文献10

二级参考文献81

  • 1熊诗松,姚光弼,徐道振,张定凤,陆志檬,傅希贤,邬祥惠,童葵塘.国产基因工程干扰素α1治疗慢性乙型肝炎的临床研究[J].中华消化杂志,1995,15(4):194-197. 被引量:11
  • 2[1]Ramm GA, Carr SC, Bridle KR, Li L, Britton RS, Crawford DH, Vogler CA,Bacon BR, Tracy TF. Morphology of liver repair following cholestatic liver injury:resolution of ductal hyperplasia, matrix deposition and regression of myofibroblasts. Liver, 2000;20:387- 396
  • 3[2]Kapoor D, Kumar N. Hepatic fibrosis: pathobiology and management. Trop Gastroenterol, 2000;21:114 - 117
  • 4[3]Ala-Kokko L, Pihlajaemi T, Myers J. Gene expressions of type Ⅰ, Ⅲ and Ⅳ collagens in hepatic fibrosis induced by dimethylnitrosamine in the rat. Biochen J,1987;244:75-79
  • 5[4]Casu A, Canepa M, Nanni G. Perisinusoidal stellate cells or Ito cells and their role in hepatic fibrosis. Pathologica, 1994;86:467-499,410
  • 6[5]Friedman SL. Molecular mechanisms of hepatic fibrosis and principles of therapy.J Gastroenterol, 1997; 32: 424 - 430
  • 7[6]Wu J, Zern MA. Hepatic stellate cells: a target for the treatment of liver fibrosis.J Gastroenterol, 2000; 35: 665 - 672
  • 8[7]Davis BH, Rapp UR, Davidson NO. Retinoic acid and transforming growth factor beta differentially inhibit platelet-derived-growth-factor-induced Ito-cell activation.Biochem J, 1991; 278 (Pt 1 ): 43 - 47
  • 9[8]Tsukamoto H. Cytokine regulation of hepatic stellate cells in liver fibrosis. Alcohol Clin Exp Res, 1999; 23: 911 - 916
  • 10[9]Friedman SL. Stellate cell activation in alcoholic fibrosis - an overview. Alcohol Clin Exp Res, 1999;23:904 - 910

共引文献14161

同被引文献136

引证文献12

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部